Skip to main content

Table 3 Patient characteristics at baseline

From: Development and proof-of-concept of a multicenter, patient-centered cancer registry for breast cancer patients with metastatic disease—the “Breast cancer care for patients with metastatic disease” (BRE-4-MED) registry

BRE-4-MED participants with baseline information

Female sex, n (%)

30 (96.8)

Age, mean (std), years

57.1 (± 13.5)

Time since diagnosis of MBC, median (IQR), months

21.0 (7–45)

Care given by family member*, n (%)

6 (21.4)

Returned questionnaires of family members*, n (%)

15 (50.0)

Number of metastasis location, n (%)

 1

9 (29.0)

 2

10 (32.3)

 3

5 (16.1)

 4

5 (16.1)

 5

1 (3.2)

 6

1 (3.2)

Kind of administered medication, n (%)

 No information on medication specified

1 (3.2)

 Oral only

2 (6.5)

 Oral + subcutaneous

1 (3.2)

 IV only

14 (45.2)

 IV + oral

11 (35.5)

 IV + oral and subcutaneous

2 (6.5)

  1. *Analyses were restricted to patients without missing values